Thank you and see you next year!

en English

Science and Regulatory

Generic and Biosimilar Sciences and Regulatory Issues

Our science and regulatory affairs tracks will provide up-to-date insight and context to today’s developments and trends so you can better navigate the twists and turns of the regulatory landscape for generic and biosimilar drug applications. You will have the opportunity to hear from subject matter experts, as well as engage with them and other experts from FDA, industry, and academia, to better inform your business strategies and optimize your results.

Who should attend:

Possible job titles include:
Regulatory Affairs, Medical Affairs, Business Development, Program Management, Policy, Commercial Development, Scientific Affairs, Research Analyst

About GRx+Biosims 2021

GRx+Biosims 2021 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development; the regulatory process and approvals; and the evolving policy landscape.

Skip to content